Latest Victhom Human Bionic (VICHF) Headlines IIR
Post# of 1
Posted On: 03/12/2014 12:54:37 AM
Latest Victhom Human Bionic (VICHF) Headlines
IIROC: Halt, VICTHOM HUMAN BIONICS INC
Marketwire Canada - Mon Apr 29, 7:11AM CDT
The following issues have been halted by IIROC / L'OCRCVM a suspendu la negociation des titres suivants :
IIROC Trading Halt - VHB
CNW Group - Mon Apr 29, 7:09AM CDT
The following issues have been halted by IIROC:
Ergoresearch Ltd announces closing of a $6.36 million private placement equity offering
CNW Group - Thu Apr 25, 6:25AM CDT
Ergoresearch Ltd. (TSXV: ERG) ("Ergoresearch") announce today that it has closed a private placement (the "Private Placement") of 10,258,065 common shares at a price of $0.62 per common share for gross proceeds of $6.36 million. Following closing of the Private Placement, 69,889,340 common shares are issued and outstanding. The securities issued under the Private Placement are subject to a four-month hold period ending on August 25(th), 2013.
The Superior Court of Québec Approves the Plan of Arrangement Relating to the Acquisition of Victhom Human Bionics Inc. by Ergoresearch Ltd.
CNW Group - Wed Apr 24, 4:21PM CDT
Ergoresearch to acquire Victhom
Victhom Human Bionics Inc. shareholders approve plan of arrangement with Ergoresearch Inc.
CNW Group - Tue Apr 23, 2:20PM CDT
Victhom Human Bionics Inc. (TSXV: VHB) ("Victhom") is pleased to announce that its shareholders have approved the sale of all of the outstanding securities of Victhom to Ergoresearch Inc. (the "Purchaser"), a direct wholly-owned subsidiary of Ergoresearch Ltd. (TSXV: ERG) ("Ergoresearch"), pursuant to a plan of arrangement (the"Plan of Arrangement"). On March 14, 2013, Victhom and Ergoresearch jointly announced that they had entered into an arrangement agreement with the Purchaser (the "Arrangement") pursuant to which Victhom will ultimately be acquired and taken private by the Purchaser and current shareholders of Victhom will receive an all-cash consideration for their outstanding common shares and Series A preferred shares of Victhom.
Victhom announces Tier classification change
CNW Group - Tue Jan 22, 3:01PM CST
Victhom Human Bionics Inc. ("Victhom") (TSXV: VHB) announced that, effective the close of trading today January 22, 2013, Victhom's Tier classification changed from Tier 1 to Tier 2. Victhom's Tier classification has changed from Tier 1 to Tier 2 because it has not maintained the TSX Venture Exchange's Tier 1 continued listing requirements.
IIROC: Halt, VICTHOM HUMAN BIONICS INC
Marketwire Canada - Mon Apr 29, 7:11AM CDT
The following issues have been halted by IIROC / L'OCRCVM a suspendu la negociation des titres suivants :
IIROC Trading Halt - VHB
CNW Group - Mon Apr 29, 7:09AM CDT
The following issues have been halted by IIROC:
Ergoresearch Ltd announces closing of a $6.36 million private placement equity offering
CNW Group - Thu Apr 25, 6:25AM CDT
Ergoresearch Ltd. (TSXV: ERG) ("Ergoresearch") announce today that it has closed a private placement (the "Private Placement") of 10,258,065 common shares at a price of $0.62 per common share for gross proceeds of $6.36 million. Following closing of the Private Placement, 69,889,340 common shares are issued and outstanding. The securities issued under the Private Placement are subject to a four-month hold period ending on August 25(th), 2013.
The Superior Court of Québec Approves the Plan of Arrangement Relating to the Acquisition of Victhom Human Bionics Inc. by Ergoresearch Ltd.
CNW Group - Wed Apr 24, 4:21PM CDT
Ergoresearch to acquire Victhom
Victhom Human Bionics Inc. shareholders approve plan of arrangement with Ergoresearch Inc.
CNW Group - Tue Apr 23, 2:20PM CDT
Victhom Human Bionics Inc. (TSXV: VHB) ("Victhom") is pleased to announce that its shareholders have approved the sale of all of the outstanding securities of Victhom to Ergoresearch Inc. (the "Purchaser"), a direct wholly-owned subsidiary of Ergoresearch Ltd. (TSXV: ERG) ("Ergoresearch"), pursuant to a plan of arrangement (the"Plan of Arrangement"). On March 14, 2013, Victhom and Ergoresearch jointly announced that they had entered into an arrangement agreement with the Purchaser (the "Arrangement") pursuant to which Victhom will ultimately be acquired and taken private by the Purchaser and current shareholders of Victhom will receive an all-cash consideration for their outstanding common shares and Series A preferred shares of Victhom.
Victhom announces Tier classification change
CNW Group - Tue Jan 22, 3:01PM CST
Victhom Human Bionics Inc. ("Victhom") (TSXV: VHB) announced that, effective the close of trading today January 22, 2013, Victhom's Tier classification changed from Tier 1 to Tier 2. Victhom's Tier classification has changed from Tier 1 to Tier 2 because it has not maintained the TSX Venture Exchange's Tier 1 continued listing requirements.
(0)
(0)Victhom Human Bionic (VICHF) Stock Research Links
Scroll down for more posts ▼